U.S. Markets open in 9 hrs 12 mins

Today's Research Reports on Trending Tickers: Novavax and ACADIA Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / November 27, 2018 / Wall Street closed up on Monday as oil prices stabilized and giant tech stocks such as the FAANG (Facebook, Amazon, Apple, Netflix and Google-parent Alphabet), bounced after last week’s selloff. The Dow Jones Industrial Average jumped 1.46 percent to close at 24,640.24, while the S&P 500 Index gained 1.55 percent to close at 2,673.45. The Nasdaq Composite Index advanced 2.06 percent to close at 7,081.85.

Ilya Feygin, senior strategist at WallachBeth Capital, said that, "Last week there was a lot of indiscriminate selling, it's almost too late to sell some of these tech names. They've gotten down to a point where companies like Facebook are trading around 18 times earnings, which is not too far from the market multiple."

"Some of these names needed to bounce a bit," Feygin added.

The Market Edge Initiates Coverage on:

Novavax, Inc.
https://marketedgereport.com/report/NVAX/

ACADIA Pharmaceuticals Inc.
https://marketedgereport.com/report/ACAD/

Novavax’s stock jumped 7.56% Monday, to close the day at $1.85. The stock recorded a trading volume of 8,515,288 shares, which was above its three months average volume of 6,219,787 shares. In the last year, Novavax’s shares have traded in a range of 1.05 - 2.75. The share price has gained 76.19% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.85 is above its 200-day moving average of $1.59. Shares of Novavax have gained roughly 3.93 percent in the past month and are up 49.19 percent year-to-date.

Access The Market Edge's Novavax, Inc. Research Report:
https://marketedgereport.com/report/NVAX/

On Monday, shares of ACADIA Pharmaceuticals recorded a trading volume of 1,020,455 shares, which was below the three months average volume of 2,765,050 shares. The stock ended the day 5.13% higher at $19.46. The share price has fallen 41.01% from its 52 week high with a 52 week trading range of 12.77 - 32.99. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $20.50 is above its 200-day moving average of $17.48. Shares of ACADIA Pharmaceuticals have fallen roughly 10.49 percent in the past month and are down 35.37 percent year-to-date.

Access The Market Edge's ACADIA Pharmaceuticals Inc. Research Report:
https://marketedgereport.com/report/ACAD/

Our Actionable Research on Novavax, Inc. (NASDAQ : NVAX ) and ACADIA Pharmaceuticals Inc. (NASDAQ : ACAD ) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: The Market Edge